• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[肾衰继发性甲状旁腺功能亢进的治疗:骨化三醇、司维拉姆和西那卡塞的作用]

[Treatment of secondary hyperparathyroidism in renal insufficiency: role of calcitriol, sevelamer and cinacalcet].

作者信息

Bonny O, Burnier M

机构信息

Division de néphrologie, CHUV, Département de pharmacologie et de toxicologie, Université de Lausanne, 1011 Lausanne.

出版信息

Rev Med Suisse. 2008 Mar 5;4(147):589-92, 594-5.

PMID:18402017
Abstract

Along with the decrease in kidney function arises a secondary hyperparathyroidism, which constitutes one of the most important risk factor for mortality in patients suffering from renal insufficiency. Treating secondary hyperparathyroidism is challenging, as most of the parameters of mineral metabolism are interconnected. We review here the pathophysiology and treatment options of this entity.

摘要

随着肾功能下降会出现继发性甲状旁腺功能亢进,这是肾功能不全患者死亡的最重要危险因素之一。治疗继发性甲状旁腺功能亢进具有挑战性,因为大多数矿物质代谢参数都是相互关联的。我们在此综述该病症的病理生理学和治疗选择。

相似文献

1
[Treatment of secondary hyperparathyroidism in renal insufficiency: role of calcitriol, sevelamer and cinacalcet].[肾衰继发性甲状旁腺功能亢进的治疗:骨化三醇、司维拉姆和西那卡塞的作用]
Rev Med Suisse. 2008 Mar 5;4(147):589-92, 594-5.
2
[Cinacalcet treatment for secondary hyperparathyroidism in dialysis patients in real-world clinical practice - the ECHO observational study: French experience].[西那卡塞治疗透析患者继发性甲状旁腺功能亢进的真实世界临床实践——ECHO观察性研究:法国经验]
Nephrol Ther. 2012 Dec;8(7):527-33. doi: 10.1016/j.nephro.2012.05.002. Epub 2012 Sep 25.
3
CKD-MBD: impact on management of kidney disease.慢性肾脏病-矿物质和骨异常:对肾脏疾病管理的影响
Clin Exp Nephrol. 2007 Dec;11(4):261-268. doi: 10.1007/s10157-007-0492-5. Epub 2007 Dec 21.
4
[Treatment of secondary hyperparathyroidism resistant to conventional therapy and tertiary hyperparathyroidism with Cinacalcet: an efficiency strategy].[西那卡塞治疗对传统治疗耐药的继发性甲状旁腺功能亢进和三发性甲状旁腺功能亢进:一种有效策略]
Nephrol Ther. 2010 Apr;6(2):105-10. doi: 10.1016/j.nephro.2009.12.004. Epub 2010 Feb 24.
5
Regression of vascular calcification in a patient treated with cinacalcet: a case report.依帕司他联合甲钴胺治疗糖尿病周围神经病变的临床疗效观察
Nefrologia. 2011;31(5):602-6. doi: 10.3265/Nefrologia.pre2011.May.10869.
6
[CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Parathyroid interventions: final one piece in the management of uremic SHPT patients].[慢性肾脏病-矿物质和骨异常(CKD-MBD)。甲状旁腺干预:尿毒症性继发性甲状旁腺功能亢进患者管理的最后一环]
Clin Calcium. 2010 Jul;20(7):1104-10.
7
[Management of secondary hyperparathyroidism].[继发性甲状旁腺功能亢进的管理]
Clin Calcium. 2005 Sep;15 Suppl 1:217-24.
8
Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients.骨化三醇和西那卡塞联合治疗血液透析患者重度继发性甲状旁腺功能亢进时,胆钙化醇可进一步降低甲状旁腺激素水平。
Nutrients. 2018 Feb 10;10(2):196. doi: 10.3390/nu10020196.
9
[Analysis of the efficacy and factors influencing the response of secondary hyperparathyroidism patients on hemodialysis to cinacalcet].[血液透析继发性甲状旁腺功能亢进患者对西那卡塞反应的疗效及影响因素分析]
Nefrologia. 2010;30(4):443-51. doi: 10.3265/Nefrologia.pre2010.May.10451.
10
Fibroblast growth factor-23 helps explain the biphasic cardiovascular effects of vitamin D in chronic kidney disease.成纤维细胞生长因子 23 有助于解释维生素 D 在慢性肾脏病中的双相心血管效应。
Int J Biol Sci. 2012;8(5):663-71. doi: 10.7150/ijbs.3886. Epub 2012 May 5.